Search

everythinglearnresearchcommunity

for

Search:↓

Using testosterone-stimulated weanling rats can effectively replace castrated rats for anti-androgen testing, reducing animal stress.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Wedelolactone may help treat lung fibrosis by reducing inflammation and lung damage.

The NUDT15 R139C variant causes thiopurine-induced leukocytopenia through a different mechanism than previously thought in Japanese patients with inflammatory bowel disease.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Spanlastics effectively deliver Rizatriptan Benzoate with high efficiency and controlled release.

Predstanormix Duo is a safe and effective new drug for treating urinary symptoms from BPH.

Tetracycline can stick to hair follicles and potentially cause hair loss.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

Diphenyl cresyl phosphate has low toxicity but can harm the liver, kidneys, adrenal glands, and testicles at high doses.

Using 5-butylpicolinate esters improves the sensitivity and reliability of detecting testosterone and dihydrotestosterone in saliva.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

The new hair product quickly reduces hair shedding in women.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Switching to generic tacrolimus was safe, effective, and saved money.

The FDA did not approve a testosterone drug because of safety concerns.

The procedure accurately measures 5-alpha-dihydrotestosterone in blood, useful for standard tests.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

The new drug delivery system effectively targets lung cancer cells.

Oral tetracycline reduces fat breakdown in hair lipids.

Dovobet ointment used overnight effectively reduces scalp psoriasis severity and itch.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

PDRN from salmon may slow skin aging by improving skin quality and reducing inflammation.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.